CGEM
Ticker
Cullinan Therapeutics, Inc.
CGEM · Healthcare · Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the Unite…Cullinan Therapeutics, Inc. (CGEM), in the Healthcare sector, has 11 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 3 purchases and 8 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 10. The most active filer was Jennifer Michaelson with 7 filings.
Add to watchlistFilings, ttm
11
3 buys · 8 sells · 1 late
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$15.0M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 8
Filed Sep 10
ADViAverage daily dollar volume
$20.1M
market data
Share price · 12M
$20.63 (+228.5%)
Adjusted for splits and dividends.
Volume by month
Buys $13.3M
Sells $1.9M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
JMRecent filings
Jennifer MichaelsonSALE
Chief Scientific Officer
$173K8,000 sh × $21.57
Exec Sep 8
Filed Sep 10 · 9:22 AM ET Jennifer MichaelsonSALE Chief Scientific Officer $608K
30,000 sh × $20.26
Exec Aug 13
Filed Aug 14 · 5:00 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $143K
8,000 sh × $17.82
Exec Jul 6
Filed Jul 7 · 5:00 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $114K
7,800 sh × $14.60
Exec May 5
Filed May 6 · 5:30 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $125K
8,000 sh × $15.68
Exec Mar 5
Filed Mar 9 · 5:30 PM ET Nadim AhmedSALE President and CEO $196K
13,515 sh × $14.47
Exec Feb 24
Filed Feb 25 · 5:30 PM ET Nadim AhmedSALE President and CEO $223K
16,381 sh × $13.62
Exec Feb 20
Filed Feb 23 · 5:30 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $114K
8,000 sh × $14.30
Exec Feb 20
Filed Feb 23 · 5:30 PM ET Lynx1 Capital Management LPPURCHASE 10% owner $1.4M
165,667 sh × $8.40
Exec Oct 28 2025
Filed Oct 30 2025 · 5:13 PM ET Lynx1 Capital Management LPPURCHASE 10% owner $2.1M
248,749 sh across 4 lots
Exec Oct 14 2025
Filed Oct 21 2025 · 7:00 PM ET † Lynx1 Capital Management LPPURCHASE 10% owner $9.8M
1,459,641 sh across 3 lots
Exec Oct 8 2025
Filed Oct 10 2025 · 6:58 PM ET Nadim AhmedSALE President and CEO $107K
12,529 sh × $8.53
Exec Feb 25 2025
Filed Feb 27 2025 · 5:30 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $125K
8,000 sh × $15.64
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET Jennifer MichaelsonSALE Chief Scientific Officer $145K
8,000 sh × $18.09
Exec Sep 5 2024
Filed Sep 9 2024 · 5:30 PM ET